CTRI/2016/07/007081尚未招募4 期
A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events - IVVE
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 3,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •New York Heart Association(NYHA) functional class II, III and IV.
排除标准
- •a) Anaphylactic reaction to a previous dose of TIV.
- •b) Known IgE-mediated hypersensitivity to eggs manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock.
- •c) Guillain-Barré syndrome within eight weeks of a previous influenza vaccine.
- •d) Anaphylactic reaction to neomycin.
- •e) Patients who have had influenza vaccine in two of the three previous years.
- •f) Patients with severe valvular disease that are candidates for surgical or percutaneous valve repair or replacement.
研究者
相似试验
已完成
不适用
Influenza vaccination strategies in haematological cancersInfluenza vaccinationHaematological malignancyInfection - Other infectious diseasesCancer - MyelomaCancer - Leukaemia - Chronic leukaemiaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12622000454774Peter MacCallum Cancer Centre130
进行中(未招募)
1 期
A Study Promoting the Influenza Response in the ElderlyThe trial is aimed to improve the efficiency of the seasonal influenza vaccine. Healthy volunteers who are positive for cytomegalovirus (CMV) will be recruited and given anti-viral treatment. We hypothesise that this will reduce their viral load and thereby reduce the proportion of T cells committed to CMV. This will then facilitate the development of an optimal response against the influenza vaccine.EUCTR2011-000092-13-GB
已完成
不适用
Clinical study of influenza vaccine in infants; dose and immunogenicityinfluenzaJPRN-UMIN000000494The Research Foundation for Microbial Diseases of Osaka University200
已完成
不适用
Study of the Influenza vaccine immune response using PMMA dialyzer.JPRN-UMIN000019455Oita University Hospital Blood purification center120
已完成
不适用
Study of the Influenza vaccine immune response using PMMA dialyzer.End-stage renal disease requiring hemodialysisJPRN-UMIN000015853Oita naika clinic50
